CNTB
CNTB
NASDAQ · Biotechnology

Connect Biopharma Holdings L

$2.85
-0.05 (-1.72%)
As of Mar 31, 3:11 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +621.4% upside
Low Target $15.18
Average Target $20.56
High Target $23.56
Current Price $2.85
Current
$2.85
Target
$20.56
$15.18 $20.56 avg $23.56
Scenario Analysis
Bear Case
$15.18
432.6%
Low target
Base Case
$20.56
+621.4%
Avg target
Bull Case
$23.56
+726.7%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$3.74
-23.8% from high
52-Week Low
$0.51
+458.8% from low
Target vs 52W High
$20.56
+449.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%